Boston Common Asset Management LLC Lowers Stock Position in Roche Holding AG $RHHBY

Boston Common Asset Management LLC trimmed its position in shares of Roche Holding AG (OTCMKTS:RHHBY) by 7.9% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 339,393 shares of the company’s stock after selling 29,160 shares during the period. Boston Common Asset Management LLC’s holdings in Roche were worth $17,575,000 as of its most recent SEC filing.

Several other large investors have also made changes to their positions in RHHBY. Curio Wealth LLC acquired a new position in Roche in the third quarter valued at $25,000. Oakworth Capital Inc. acquired a new stake in Roche during the third quarter worth about $57,000. Salomon & Ludwin LLC increased its stake in Roche by 256.6% during the third quarter. Salomon & Ludwin LLC now owns 2,853 shares of the company’s stock worth $129,000 after acquiring an additional 2,053 shares during the last quarter. Douglass Winthrop Advisors LLC purchased a new position in shares of Roche in the 3rd quarter worth about $201,000. Finally, Albert D Mason Inc. acquired a new position in shares of Roche in the 4th quarter valued at about $207,000.

Analysts Set New Price Targets

A number of brokerages have recently issued reports on RHHBY. Morgan Stanley reiterated an “underweight” rating on shares of Roche in a report on Wednesday, February 4th. Barclays upgraded shares of Roche from an “equal weight” rating to an “overweight” rating in a report on Tuesday, January 6th. JPMorgan Chase & Co. upgraded shares of Roche from an “underweight” rating to a “neutral” rating in a research note on Monday, December 8th. Zacks Research raised shares of Roche from a “strong sell” rating to a “hold” rating in a research report on Monday, January 5th. Finally, Citigroup assumed coverage on shares of Roche in a research note on Tuesday, January 27th. They issued a “buy” rating on the stock. Four research analysts have rated the stock with a Buy rating, five have assigned a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat, the stock has an average rating of “Hold” and a consensus target price of $57.00.

Roche Trading Up 1.1%

RHHBY stock opened at $48.84 on Tuesday. The company has a current ratio of 1.38, a quick ratio of 1.12 and a debt-to-equity ratio of 0.72. Roche Holding AG has a 1 year low of $34.75 and a 1 year high of $60.85. The stock has a 50-day simple moving average of $55.10 and a 200-day simple moving average of $49.67.

Roche Profile

Roche Holding AG is a Swiss multinational healthcare company headquartered in Basel, founded in 1896 by Fritz Hoffmann‑La Roche. The company operates primarily through two complementary divisions — Pharmaceuticals and Diagnostics — and is known for integrating drug development with diagnostic capabilities to advance personalized healthcare. In the United States and other international markets, shares trade as American Depositary Receipts under the ticker RHHBY (OTCMKTS:RHHBY).

In pharmaceuticals, Roche focuses on developing and commercializing prescription medicines across therapeutic areas including oncology, immunology, infectious diseases and neuroscience, with a notable emphasis on targeted biologics and personalized therapies.